Vanda Pharmaceuticals
Clinical trials sponsored by Vanda Pharmaceuticals, explained in plain language.
-
New pill formula tested in patients with schizophrenia or bipolar disorder
Disease control CompletedThis study tested whether a new tablet (VHX-896) works the same as the approved drug iloperidone in 26 adults with schizophrenia or bipolar I disorder. Participants took both versions under steady conditions to compare drug levels and side effects. The goal was to see if the new …
Phase: PHASE1 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Promising new drug shows hope for rare, severe skin disease
Disease control CompletedThis study tested a new drug called imsidolimab in 8 adults with active generalized pustular psoriasis (GPP), a rare and serious skin condition that causes painful pustules. The goal was to see if the drug could improve skin symptoms and was safe. Results showed that most partici…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 01, 2026 15:56 UTC
-
New hope for rare, severe psoriasis: drug shows promise in final trial
Disease control CompletedThis study tested a new medicine called imsidolimab for adults with generalized pustular psoriasis (GPP), a rare and serious skin condition that causes painful pus-filled bumps. The trial compared the drug to a placebo to see if it could clear or nearly clear the skin. 45 people …
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
New drug shows promise for painful skin condition
Symptom relief CompletedThis study tested a drug called imsidolimab in 149 people with hidradenitis suppurativa, a chronic skin disease that causes painful lumps. The goal was to see if the drug reduces the number of abscesses and inflamed nodules compared to a placebo over 16 weeks. The trial is now co…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC